GlassScriptPhysician profile
Yasser Etman
NPI 1295949980
$1,558.15
in general payments reported to CMS, 2019-2025
16 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $75.11 · 2022: $46.73 · 2023: $14.95 · 2024: $221 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298 · Education: $40.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.68 |
| Education | $40.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $341.63 | 2019-2024 | Hillrom - Vest System Model 105 Home Care |
| Glaxosmithkline, LLC. | $271.26 | 2019-2025 | Nucala |
| Sunovion Pharmaceuticals INC. | $184.67 | 2019-2020 | |
| Erbe USA INC | $147.83 | 2024 | Vio3/Apc3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.06 | 2019 | |
| Genentech USA, INC. | $89.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $82.86 | 2019-2025 | Breztri, Tezspire |
| Electromed, INC. | $61.29 | 2019-2023 | Smartvest |
| Grifols USA, LLC | $50.66 | 2019 | |
| Insmed, INC. | $46.57 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $43.73 | 2019 | |
| Merck Sharp & Dohme LLC | $27.85 | 2019 | |
| Gilead Sciences, INC. | $19.97 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $14.59 | 2024 | Opsumit, Uptravi |
| Philips North America LLC | $14.42 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasser Etman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.